AGÑÇÓ鼯ÍŹٷ½ÍøÕ¾

ÄúÏÖÔÚµÄλÖãº ÍøÕ¾Ê×Ò³>´ÙÏúÖÐÐÄ

ÅÁ½ðÉ­²¡

2022-03-03

±³¾°



ÅÁ½ðÉ­²¡£¨Parkinson¡¯s disease, PD£©ÊdzýÁËÕâ¸ö²¡Ö®Íâ £¬ÊÀ½çµÚ¶þ´óµÄÉñ¾­ÍËÐÐÐÔ¼²²¡¡£ÎªÁ˼ÍÄî·¢ÏÖÕâÒ»¼²²¡µÄÓ¢¹úÒ½Éúղķ˹¡¤ÅÁ½ðÉ­ £¬ÈËÃǽ«ËûµÄÉúÈÕ¡ª¡ª4ÔÂ11ÈÕÈ·¶¨Îª¡°ÊÀ½çÅÁ½ðÉ­ÈÕ¡±¡£



ÅÁ½ðÉ­²¡µÄÖ÷ÒªÖ¢×´±íÏÖΪÔ˶¯Õϰ­ £¬ÈçÔ˶¯³Ù»º£¨bradykinesia£©¡¢½©Ö±£¨rigidity£©¡¢¾²Ö¹ÐÔÕð²ü£¨tremor£©µÈ¡£³ý´ËÖ®ÍâÅÁ½ðÉ­»¼ÕßÒ²±íÏÖ³öÁ˸оõÕϰ­ºÍÈÏÖª¹¦ÄÜÕϰ­µÈ·ÇÔ˶¯Ö¢×´¡£Ò»Ïî2016ÄêµÄÑо¿ÏÔʾ £¬60ËêÒÔÉÏÀÏÄêÈËȺÖÐÅÁ½ðÉ­²¡µÄ»¼²¡ÂÊԼΪ1%-2% £»¶øÔÚ80ËêÒÔÉÏÈËȺÖÐ £¬ÕâÒ»±ÈÀýÔò»áÉÏÉýÖÁ4%×óÓÒ1¡£Ä¿Ç° £¬ÎÒ¹úµÄÅÁ½ðÉ­»¼ÕßÒѾ­´ïµ½ÁË200ÍòÈË £¬Õ¼È«ÊÀ½çÅÁ½ðÉ­²¡È˵ÄÒ»°ë×óÓÒ¡£ÔÚÎÒ¹úÀÏÁ仯Öð²½¼ÓÉîµÄ±³¾°Ï £¬ÅÁ½ðÉ­²¡ÒѾ­³ÉΪÍþвÀÏÄêÈËȺÉíÐĽ¡¿µµÄÒ»´ó¡°É±ÊÖ¡±¡£



ÅÁ½ðÉ­²¡×îΪͻ³öµÄ²¡Àí¸Ä±äÊÇÖÐÄÔºÚÖÊÖжà°Í°·ÄÜÉñ¾­ÔªµÄ±äÐÔºÍËÀÍö¡£ÁíÍâÈËÃÇ·¢ÏÖ £¬²Ð´æÉñ¾­ÔªÖзÒ×СÌåµÄÐγɺͦÁ-Í»´¥ºËµ°°×µÄ¾Û¼¯Ò²ÊÇÅÁ½ðÉ­²¡µÄµäÐÍÌØÕ÷Ö®Ò»¡£ÅÁ½ðÉ­²¡µÄ²¡ÒòÖÁ½ñδÃ÷ £¬Ö¤¾ÝÏÔʾÒÅ´«¡¢»·¾³ÎÛȾ¡¢Ë¥ÀϵÈÒòËØ¾ùÔÚÅÁ½ðÉ­²¡µÄ·¢ÉúÖаçÑÝÁËÒ»¶¨µÄ½ÇÉ«¡£



ΪÁËÑо¿ÅÁ½ðÉ­²¡µÄ·¢²¡Ô­ÒòÒÔ¼°Ì½Ë÷еÄÁÙ´²µÄÖÎÁÆÊÖ¶Î £¬ÖƱ¸ÓÐЧµÄÅÁ½ðÉ­²¡¶¯ÎïÄ£ÐÍÓÐ×ÅÖØÒªµÄÒâÒå¡£ÔÚ±¾ÎÄÖÐÎÒÃǽ«½éÉÜ3ÖÖÖ÷Á÷µÄÅÁ½ðÉ­²¡µÄ¶¯ÎïÄ£Ð͵ÄÔ­ÀíºÍÖÆ±¸·½·¨¡£¶øÔÚÏÂÆÚ £¬ÎÒÃǽ«½éÉܼìÑé´óСÊóÅÁ½ðÉ­Ä£ÐÍÔìģЧ¹ûµÄ²¡ÀíºÍÐÐΪѧ·½·¨¡£



1.MPTPÓÕµ¼Ð¡ÊóÅÁ½ðÉ­Ä£ÐÍ



1982Äê £¬7¸öÀ´×Ô¼ÓÀû¸£ÄáÑÇÖÝÊ¥¿ËÀ­À­Ïصġ°æÒƤʿ¡±ÔÚÎüʳÁËÒ»Öֺϳɺ󱻽ô¼±ËÍÍùÒ½Ôº¾ÈÖΡ£Ò½Éú¾ªÆæµØ·¢ÏÖ £¬Õâ7λ»¼ÕßËäÈ»Äê¼ÍÇáÇá £¬Ðж¯È´Ïñ°ÙËêÀÏÈËÒ»Ñù³Ù»º £¬²¢°éËæÓÐÖ«ÌåÕð²üµÄÏÖÏó £¬ºÍÅÁ½ðÉ­²¡µÄ±íÏÖÊ®·ÖÏàËÆ¡£½øÒ»²½µÄ¼ìÑé±íÃ÷ £¬ÕâÅúºÏ³ÉÖк¬ÓÐÒ»ÖÖÃûΪ1-¼×»ù-4-±½»ù-1,2,3,6-ËÄÇâßÁण¨1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, MPTP£©µÄÔÓÖÊ2¡£1984Äê £¬Ë¹Ì¹¸£´óѧµÄÉñ¾­Ñ§¼ÒÍþÁ®¡¤À¼Ë¹¶ÙÈ·ÈÏMPTPÕýÊǵ¼ÖÂÕâЩÄêÇáÈ˳öÏÖÅÁ½ðÉ­ÑùÖ¢×´µÄ×ï¿ý»öÊ×3¡£



´ÓÔ­ÀíÀ´¿´ £¬MPTP±¾Éí¶Ôϸ°û²¢ÎÞ¶¾º¦×÷Óᣵ«Êǵ±MPTP½øÈëÌåÄÚºó £¬ÓÉÓÚ×ÔÉíÁ¼ºÃµÄÖ¬ÈÜÐÔ £¬MPTP¿ÉÒÔÇáÒ×´©¹ýѪÄÔÆÁÕÏ£¨blood-brain barrier, BBB£©½øÈëÖÐÊàÉñ¾­ÏµÍ³4¡£¶øÔÚÄÔÖÐ £¬MPTP»á±»Éñ¾­½ºÖÊϸ°ûÖеĵ¥°·Ñõ»¯Ã¸B£¨MAO-B£©´úлΪһÖÖÃûΪMPDP +µÄÖмäÌå¡£¶ø¸ÃÖмäÌåÔÙ¾­¹ý½øÒ»²½µÄÑõ»¯ £¬×îÖÕÐγÉÓж¾µÄ´úлÎï¼×»ù-±½»ùËÄÇâßÁà¤æfÑΣ¨MPP +£©5¡£



MPP+µÄ½á¹¹½Ó½ü¶à°Í°· £¬Òò´Ë»á´íÎ󵨱»ÖÐÄÔ¶à°Í°·Éñ¾­ÔªÄ¤ÉϵĶà°Í°·×ªÔËÌ壨dopamine transporter, DAT£©Ñ¡ÔñÐÔÖØÎüÊÕ½øÈëϸ°ûÄÚ6¡£¶øÒ»µ©½øÈëϸ°û £¬MPP+Ôò»á¡°Ð×Ïà±Ï¶¡± £¬Ëü»áÒÖÖÆÏßÁ£ÌåºôÎüÁ´¸´ºÏÌåIµÄ»îÐÔ7 £¬´Ó¶ø×è¶Ïµç×Ó×ªÒÆÁ´ £¬¼õÉÙATPµÄÉú³É²¢´Ù½ø»îÐÔÑõ(reactive oxygen species, ROS)µÄ²úÉú £¬×îÖÕÔì³ÉÉñ¾­ÔªµÄËðÉË8¡£

AGÑÇÓ鼯ÍÅ¡¤(Öйú)¹Ù·½ÍøÕ¾
AGÑÇÓ鼯ÍÅ¡¤(Öйú)¹Ù·½ÍøÕ¾

ͼ1 MPTPµÄ´úл;¾¶ºÍMPP+ÔÚ°ûÄڵķ¾¶







ÕýÒòΪMPTPÊǵÚÒ»¸öÒ²ÊÇĿǰÄܹ»ÔÚÈËÀàÉíÉϸ´ÏÖÅÁ½ðÉ­Ö¢×´µÄÉñ¾­¶¾ËØ£¨Ä³ÖÖÒâÒåÉÏ»¹Òª¸ÐлÕ⼸λ¼ÓÖݵÄÄêÇáÈË£© £¬MPTPÓÕµ¼µÄÅÁ½ðÉ­Ä£ÐͳÉΪÁËÔÚģʽ¶¯ÎïÉÏÑо¿ÅÁ½ðÉ­²¡ÁÙ´²ÁÆ·¨µÄ¡°½ð±ê×¼¡± £¬ÓÈÆäÊÇMPTPÓÕµ¼µÄ·ÇÈËÁ鳤ÀࣨÈçºãºÓºï£©ÅÁ½ðÉ­Ä£ÐÍ¡£¶øMPTPÓÕµ¼µÄСÊóÅÁ½ðÉ­Ä£ÐÍÓÉÓÚÔìÄ£¼¼ÊõÏà¶Ô¼òµ¥£¨Ö»ÐèÒª¸¹Ç»×¢É䣩¡¢¶Ô¶à°Í°·Éñ¾­ÔªµÄɱÉËЧ¹ûÎȶ¨Ò²µÃµ½Á˹㷺µÄÈϿɡ£²»ÉÙ¹ØÓÚ¶à°Í°·ÄÜÉñ¾­ÔªËÀÍö»úÖÆ·½ÃæµÄÑо¿¶¼²ÉÓÃMPTPÓÕµ¼µÄСÊóÅÁ½ðÉ­Ä£ÐÍ×÷ΪʵÑ鷶ʽ¡£

¶¯ÎÐÛÐÔC57BL/6 £¬´óÔ¼7-8ÖÜÁä £¬ÌåÖØ25-30 g¡£×¢ÒâMPTPÓÕµ¼µÄСÊóÅÁ½ðÉ­Ä£ÐͶԶ¯ÎïµÄÐÔ±ð¡¢ÌåÖØ¡¢ÄêÁäÉõÖÁƷϵÀ´Ô´£¨ÊÇJackson lab»¹ÊÇCharles River£©¾ù·Ç³£Ãô¸Ð¡£ÔÚÌôÑ¡¶¯ÎïµÄʱºòҪʮ·ÖСÐÄ¡£

ËÇÑø£º¶©¹ºµÄ¶¯Îﵽλºó £¬ÔÚ×¢ÉäǰÎñ±ØÊÊÓ¦ÐÔËÇÑø1ÖÜ×óÓÒ¡£ÒòΪ³¤¾àÀëÔËÊä»á¸Ä±äÄÔµÄ״̬ £¬Òò´ËÐèÒª5-7Ììʱ¼äÀ´Ê¹¶¯Îï»Ö¸´²¢ÊÊÓ¦»·¾³¡£

×¢É䣺ÔÚ×¢Éäµ±ÌìÅäÖÆºÃÐÂÏʵÄMPTPÈÜÒº £¬È»ºóÿֻ¶¯Îï°´14-20 mg/kgÌåÖØµÄ¼ÁÁ¿¸¹Ç»×¢ÉäMPTP¡£¼ä¸ô2Сʱºó½øÐÐÏÂÒ»´Î×¢Éä £¬µ±Ìì¹²½øÐÐ4´Î×¢Éä¡£

Êõºó»¤Àí£º×¢ÉäÖ®ºó´óÔ¼30·ÖÖÓ £¬Ð¡Êó¾Í»á³öÏÖÀàËÆÅÁ½ðÉ­µÄÖ¢×´ £¬Èçǿֱ»òÕð²üµÈ¡£¶øÔÚ´óÔ¼3Сʱºóδ±»´úлµÄMPTP½«»áËæ×Ŷ¯ÎïµÄÅÅйÎï±»Êͷŵ½µæÁÏÖС£Òò´ËÔÚ×¢ÉäÖ®ºóСÊóÐèÒª½øÐÐÑϸñµÄ¸ôÀëËÇÑø¡£ÆäʹÓõĵæÁÏ¡¢ÒûË®±ØÐë¾­¹ýÎÞº¦»¯´¦Àí £¬È»ºó×÷ΪҽÁÆÀ¬»ø·ÏÆú¡£´óÔ¼3-4Öܺó¿ÉÒÔ¶Ô¶¯ÎïµÄ²¡ÀíºÍÐÐΪ±íÏÖ½øÐмì²â¡£



2.6-OHDAÓÕµ¼ÅÁ½ðÉ­Ä£ÐÍ



6-ôǶà°Í°·£¨6-hydroxydopamine, 6-OHDA£©ÊǶà°Í°·µÄôÇ»ù»¯ÑÜÉúÎï £¬ÓÚ1959ÄêÊ×Ïȱ»SenohµÈÈ˳ɹ¦·ÖÀë9¡£×Ô·¢ÏÖÒÔÀ´µÄ°ë¸ö¶àÊÀ¼ÍÖÐ £¬6-OHDAÒ»Ö±ÔÚÅÁ½ðÉ­²¡µÄÁÙ´²Ç°Ñо¿ÖаçÑÝ×ÅÖØÒª½ÇÉ«¡£ÓÉUngerstedtºÍArbuthnottÔÚ1970Ä깲ͬ´´Á¢µÄµ¥²à×¢ÉäÐýתģÐͳÉΪÁËÔÚģʽ¶¯ÎïÉϱ»×îΪ¹ã·ºÊ¹ÓõÄÅÁ½ðÉ­Ä£ÐÍÖ®Ò»10¡£

6-OHDA¶ÔÉñ¾­ÔªµÄ¶¾º¦×÷ÓÃÓÐÒ»¸ö¡°Á½²½×ß¡±µÄ¹ý³Ì¡£µÚÒ»²½ÊÇÌØÒìÐÔµØÔÚ¶à°Í°·ÄÜÉñ¾­ÔªÄڵĻýÀÛ¡£ÓÉÓÚ6-OHDAµÄ½á¹¹ºÍ¶ù²è·Ó°·ÀàËÆ £¬Òò´ËÊÍ·ÅÔÚϸ°û¼äÖÊÖеÄ6-OHDA»á±»¶à°Í°·Éñ¾­Ôª°ûÌå»òÍ»ÆðÉϵĶà°Í°·×ªÔËÌå´íÎóµØÊ¶±ð²¢ÖØÎüÊÕ½øÈëϸ°û£¨Í¼2£©¡£µÚ¶þ²½ÔòÊÇϸ°û¶¾ÐÔ¡£µ±6-OHDA½øÈëÉñ¾­Ôªºó £¬Ò»·½Ã潫»á±»µ¥°·Ñõ»¯Ã¸-A£¨MAO-A£©´ß»¯ÐγɹýÑõ»¯Ç⣨H2O2£©¡£¹ýÑõ»¯Çâ±¾Éí¾ßÓкÜÇ¿µÄϸ°û¶¾ÐÔ £¬Í¬Ê±Ò²»á´¥·¢Ñõ×ÔÓÉ»ùµÄÐγÉ12¡£¶øÁíÒ»·½Ãæ £¬×Ô¶¯Ñõ»¯£¨autooxidation£©×÷ÓÃËù´óÁ¿²úÉúµÄ»îÐÔÑõºÍõ«Àà²úÎﳬ³öÁËϸ°ûÄÚ¿¹Ñõ»¯Ã¸µÄ³ÐÊÜÄÜÁ¦ £¬µ¼ÖÂϸ°û½á¹¹ºÍ´úлµÄÎÉÂÒ £¬×îÖÕ½á¹û¾ÍÊÇÉñ¾­ÔªµÄËðÉË£¨Í¼2£©¡£

AGÑÇÓ鼯ÍÅ¡¤(Öйú)¹Ù·½ÍøÕ¾
ͼ2  6-OHDA½éµ¼µÄÉñ¾­¶¾ÐÔ×÷ÓûúÖÆ



ÓëMPTP²»Í¬µÄÊÇ £¬6-OHDA²¢²»ÄÜ´©Í¸ÑªÄÔÆÁÕÏ¡£Òò´ËΪÁË´ïµ½ÖÐÊàÉñ¾­ÏµÍ³»ÙÉ˵ÄЧ¹û £¬ÔÚʹÓÃ6-OHDA½øÐÐÅÁ½ðÉ­ÔìģʱÐèҪʹÓÃÄÔÁ¢Ì嶨λעÉä¼¼Êõ½«6-OHDA×¢Èëµ½ºÚÖÊ-ÎÆ×´Ì壨striatonigral£©ÕâÒ»¶à°Í°·ÄÜͶÉäͨ·ÖС£¾ßÌåµÄ×¢Éäλµã¿ÉÒÔÊǺÚÖÊÖÂÃܲ¿£¨substantia nigra pars compacta, SNpc£©¡¢ÎÆ×´Ì壨striatum£©»òÕßλÓÚ¶þÕßÖ®¼äµÄǰÄÔÄÚ²àÊø£¨MFB£©¡£



¶¯Î6-8ÖÜÁäµÄC57/BLСÊó £¬´ÆÐÛ²»ÏÞ £¬ÌåÖØ20-25 g×óÓÒ¡£

ËÇÑø£ºÓëMPTPÓÕµ¼µÄÄ£ÐÍÏàͬ £¬¶¯Îï¶©¹ºÖ®ºóÐèÒªÖÁÉÙÊÊÓ¦ÐÔËÇÑø1ÖܺóÔÙ½øÐÐÔìÄ£ÊÖÊõ¡£

ÄÔ¶¨Î»×¢É䣺ÔÚ33GµÄHamilton×¢ÉäÆ÷»ò²£Á§µç¼«ÖÐÔ¤ÏÈÎüÈë1 ¦ÌL×óÓÒŨ¶ÈΪ3 ¦Ìg/mLµÄ6-OHDAÈÜÒº¡£Ð¡ÊóÂé×íºó¹Ì¶¨ÔÚÄÔÁ¢Ì嶨λÒÇÉÏ¡£¼ô¿ªÍ·Æ¤ºóÓÃÃÞÇ©ÇáÇá²ÁÊí¹Ç±íÃæ½«Ç°Ø¶£¨bregma£©ºÍºóض£¨lambda£©µã±©Â¶³öÀ´¡£µ÷½ÚÁ¢Ì嶨λÒÇ £¬½«Ç°Ø¶ºÍºóضµãµÄ¸ß¶Èµ÷½Úµ½Ò»Ö´ӶøÊ¹Â­¹Ç±£³Öˮƽ¡£ÒÔbregmaµãΪԭµã £¬ÕÒµ½×¢ÉäλµãËùÔÚµÄ×ø±ê £¬ÓÃÑÀ¿Æ×꽫עÉäλµãÉÏ·½µÄ­¹Ç×꿪һ¸öС¶´¡£ÔÚ6-OHDAÓÕµ¼µÄÄ£ÐÍÖÐ £¬×¢Éäλµã¿ÉÒÔÊǺÚÖÊ£¨AP -2.90 mm; ML +1.10 mm; DV -4.50 mm£© £¬Ò²¿ÉÒÔÊÇǰÄÔÄÚ²àÊø£¨AP -1.20 mm; ML +1.10 mm; DV -5.00 mm£©»òÎÆ×´Ì壨AP +0.2 mm; ML ¡À2.00 mm; DV -2.60 mm£©¡£½«²£Á§µç¼«»ò×¢ÉäÕ뻺Âý²åÈë×¢Éäλµã £¬ÒÔ0.2 ¦ÌL/minµÄËٶȽ«6-OHDA×¢É䵽Ŀ±êÄÔÇø¡£×¢Éä½áÊøºó £¬×¢ÉäÕëÓ¦¸Ã¼ÌÐøÍ£ÁôÔÚ×¢Éäλµã5·ÖÖÓ×óÓÒÒÔʹҩÎïÄܹ»³ä·ÖÀ©É¢¡£ÌáÆð×¢ÉäÕë £¬½«¶¯ÎïµÄͷƤ·ìºÏ²¢Ïû¶¾¡£

Êõºó»¤Àí£ºÄÔ¶¨Î»×¢ÉäÍê³Éºó½«¶¯Îï·ÅÔÚ¼ÓÈȰå»òµÆ¹âÏÂÕÕÉä±£³ÖÌåΡ£´ý¶¯ÎïËÕÐѺó·Å»ØÁýÖС£Êõºó3ÌìÄÚÿÌ츹ǻעÉäÒ»´Î¿¹ÉúËØ¡£´óÔ¼3-4Öܺó¿ÉÒÔ½øÐÐÐÐΪѧ¼ì²â¡£












3.»ùÓÚ¦Á-Í»´¥ºËµ°°×µÄÄ£ÐÍ

³ýÁ˶à°Í°·Éñ¾­Ôª¶ªÊ§Ö®Íâ £¬ÅÁ½ðÉ­²¡µÄÁíÒ»ÖÖµäÐ͵ÄÉñ¾­²¡Àí±êÖ¾ÊDzдæµÄÉñ¾­Ôª°ûÖÊÄÚ³öÏÖÒ»ÖÖÊÈËáÐԵİüº­Ìå £¬¼´Â·Ò×СÌ壨Lewy bodies, LBs£©¡£ÏÔ΢¾µÏ³ÊÏÖÔ²ÐεķۺìÉ«¾ùÖʽṹ¡£Â·Ò×СÌåµÄÖ÷Òª×é³É³É·ÖÊÇÒ»ÖÖ½Ð×ö¦Á-Í»´¥ºËµ°°×£¨¦Á-synuclein, ¦Á-Syn£©µÄÍ»´¥Ç°µ°°×¡£´óÁ¿Ö¤¾ÝÏÔʾ £¬¦Á-Í»´¥ºËµ°°×µÄ¾Û¼¯ºÍ·Ò×СÌåµÄÐγÉÓë¶à°Í°·Éñ¾­ÔªµÄËÀÍöÓÐ×ÅÃÜÇеÄÁªÏµ13¡£

¦Á-Í»´¥ºËµ°°×ÓÉSNCA»ùÒò±àÂë £¬ÊÇÒ»ÖÖÖ÷Òª±í´ïÔÚÍ»´¥Ç°ºÍºËÖܵĿÉÈÜÐÔµ°°×¡£¦Á-Í»´¥ºËµ°°×µÄÈ·Çй¦ÄÜÖÁ½ñÈÔ²»Çå³þ £¬²»¹ýÓÐÖ¤¾ÝÏÔʾ¿ÉÄÜÓëÍ»´¥¿ÉËÜÐÔ»òÉñ¾­µÝÖÊÊÍ·ÅÏà¹Ø¡£Õý³£×´Ì¬ÏµĦÁ-Í»´¥ºËµ°°×ÒÔµ¥Ì壨monomers£©»òÕߦÁÂÝÐý×´£¨¦Á-helical£©ÕÛµþµÄËľÛÌåÐÎʽ´æÔÚ £¬¿ÉÈܲ¢ÇÒÏÊÓоۼ¯µÄÇé¿ö £»µ«ÔÚ²¡Àí״̬Ï £¬¦Á-Í»´¥ºËµ°°×»á¸Ä±ä¹¹ÏóΪ¸»º¬¦ÂƬ״£¨¦Â-sheet£©ÕÛµþµÄ½á¹¹¡£´íÎóÕÛµþµÄ¦Á-Í»´¥ºËµ°°×»á¾Û¼¯ÆðÀ´ÐγɹѾÛÌå £¬²¢Öð½¥ÏòÏËάԭºÍ²»ÈÜÐÔÏËάµÄÐÎ̬·¢Õ¹ £¬×îÖÕ³Á»ýÔÚ·Ò×СÌåÖС£³ý´ËÖ®Íâ £¬´óÁ¿Ñо¿Ö¤¾Ý±íÃ÷ £¬´íÎóÕÛµþµÄ¦Á-Í»´¥ºËµ°°×¿ÉÒÔ±íÏÖ³öëò¡¶¾£¨prion£©µÄÐÔÖÊ £¬ÓÕ·¢ÄÚÔ´¦Á-Í»´¥ºËµ°°×µÄ´íÎóÕÛµþºÍ¾Û¼¯ £¬²¢Í¨¹ýϸ°û¼ä´«µÝµÄ·½Ê½ÔÚÉñ¾­ÔªÖ®¼äÀ©É¢¡£

Ïà±ÈÓÚʹÓÃÉñ¾­¶¾ËØÉ±É˶à°Í°·Éñ¾­ÔªµÄÅÁ½ðÉ­Ä£ÐÍ £¬»ùÓÚ¦Á-Í»´¥ºËµ°°×µÄÅÁ½ðÉ­²¡Ä£ÐÍÓÉÓÚÔÚʱ³ÌÉÏÄܹ»½ÏºÃµØÄ£ÄâÅÁ½ðÉ­²¡·¢Éú¡¢·¢Õ¹µÄÈ«¹ý³Ì £¬ÕâÓÐÀûÓÚ·¢ÏÖºÍʶ±ðеÄÖÎÁưеã¡£ÔÚÖî¶à»ùÓÚ¦Á-Í»´¥ºËµ°°×µÄÅÁ½ðÉ­Ä£ÐÍÖÐ £¬½üÄêÀ´±»×î¹ã·ºÊ¹ÓõÄÄ£ÐÍ¿ÉÒÔ¹éÄÉΪ2ÖÖ£ºÔ¤ÖÆÏËά£¨pre-performed fibrils, PFFs£©ºÍAAV²¡¶¾¿ÅÁ£Ä£ÐÍ¡£

ʹÓæÁ-Í»´¥ºËµ°°×µÄÔ¤ÖÆÏËά½øÐÐÔìÄ£Ê×ÏÈÐèÒªÖÆ±¸PFFs¡£¼ò¶øÑÔÖ® £¬Ô¤ÖÆÏËάÊ×ÏÈÔÚÌåÍâÓÉÖØ×éµÄ¦Á-Í»´¥ºËµ°°×µ¥ÌåÉú³É¡£½ÓÏÂÀ´ £¬¾Û¼¯³ÉÔ­ÏËάµÄ¦Á-Í»´¥ºËµ°°×±»ÌáÈ¡³öÀ´²¢³¬ÉùÆÆËéΪ¶ÌÏËάµÄÐÎʽ14¡£Ê¹ÓÃÄÔÁ¢Ì嶨λעÉäµÄ·½Ê½½«PFFs×¢Éä½øÄÔÄÚ £¬ÔÚ´óÔ¼12Öܺ󽫻áÓÕ·¢ÄÚÔ´¦Á-Í»´¥ºËµ°°×µÄ¾Û¼¯¡¢Á×ËữºÍ·ºËØ»¯·´Ó¦¡£

ÁíÒ»ÖÖÓÐЧµÄ·½Ê½ÊÇʹÓÃÖØ×éÏÙÏà¹Ø²¡¶¾£¨recombinant adeno-associated virus, rAAV£©ÍâÔ´¹ý±í´ïÒ°ÉúÐÍ»òµãÍ»±äÐÍ£¨ÈçA53T£©¦Á-Í»´¥ºËµ°°×¡£ÖµµÃ×¢ÒâµÄµÄÊÇ £¬¹¹½¨AAVÔØÌå²ÉÓõÄѪÇåÐÍºÍÆô¶¯×Ó £¬ÒÔ¼°²¡¶¾×¢ÉäµÄµÎ¶ÈºÍ¼ÁÁ¿¶¼»á¶Ô¦Á-Í»´¥ºËµ°°×¹ý±í´ïµÄЧÂʲúÉúÓ°Ïì15¡£Ä¿Ç°µÄÑо¿ÏÔʾ £¬Ê¹Óó£ÓõÄCMV»òÕßhSynÆô¶¯×Ó¾ù¿ÉÒÔÌṩ¸ßˮƽµÄ»ùÒò±í´ïЧÂÊ¡£ÁíÍâ £¬Ê¹ÓÃһЩת¼ºóµ÷¿ØÔª¼þ £¬ÈçÍÁ²¦Êó¸ÎÑײ¡¶¾×ªÂ¼ºóµ÷½ÚÐòÁУ¨WPRE£©»òÕßpoly(A)β°ÍͬÑù¿ÉÒÔÏÔÖøÌá¸ßת»ùÒòµÄЧÂÊ¡£

¶¯Î6-8ÖÜÁäµÄC57/BLСÊó»òPDÏà¹ØµÄת»ùÒòÊó £¬´ÆÐÛ²»ÏÞ £¬ÌåÖØ20-25 g×óÓÒ¡£

ËÇÑø£º¶¯Îï¶©¹ºÖ®ºóÐèÒªÖÁÉÙÊÊÓ¦ÐÔËÇÑø1ÖܺóÔÙ½øÐÐÄÔ¶¨Î»×¢Éä¡£

ÄÔ¶¨Î»×¢É䣺ʹÓÃ10 ¦ÌL £¬33GµÄHamilton×¢ÉäÆ÷Ô¤ÏÈÎüÈë2.5 ¦ÌL×óÓÒ¦Á-Í»´¥ºËµ°°×PFFs £¬ÆäÖЦÁ-Í»´¥ºËµ°°×ÏËάµÄº¬Á¿Ô¼Îª5 ¦Ìg¡£¶¯Î↑­ºÍµ÷ƽ²Ù×÷ÓÚ6-OHDA×¢ÉäÒ»Ö¡£¦Á-Í»´¥ºËµ°°×ͨ³£±»µ¥²à×¢ÉäÔÚÎÆ×´Ì壨AP +0.2 mm; ML ¡À2.00 mm; DV -2.60 mm£©¡£×¢ÉäÕ뻺Âý²åÈë×¢Éäλµã £¬ÒÔ0.1 ¦ÌL/minµÄËٶȽ«PFFs×¢É䵽Ŀ±êÄÔÇø¡£×¢Éä½áÊøºó £¬×¢ÉäÕëÓ¦¸Ã¼ÌÐøÍ£ÁôÔÚ×¢Éäλµã5·ÖÖÓ×óÓÒÒÔʹÏËά³ä·ÖÀ©É¢¡£×îºóÌáÆð×¢ÉäÕë £¬½«¶¯ÎïµÄͷƤ·ìºÏ²¢Ïû¶¾¡£

Èç¹ûÊDz¡¶¾×¢Éä £¬Ôò¹¹½¨AAV2/1-A53T(ÈËÀà¦Á-Í»´¥ºËµ°°×A53TµãÍ»±äÐÍ)-EGFP-WPRE²¡¶¾ÔØÌå £¬ÓÃ×¢ÉäÆ÷»ò²£Á§µç¼«ÎüÈ¡1.5 ¦ÌL £¬µÎ¶ÈΪ2-3¡Á1012 v.g./mL²¡¶¾ £¬²¢ÒÔ0.1 ¦ÌL/minµÄËٶȵ¥²à×¢ÉäÔÚºÚÖÊ£¨AP -3.1 mm; ML -1.4 mm; DV -4.4 mm£©¡£

AGÑÇÓ鼯ÍÅ¡¤(Öйú)¹Ù·½ÍøÕ¾
ͼ3  ÎÆ×´Ìå×¢ÉäµÄ×ø±êʾÒâͼ

Êõºó»¤Àí£ºÄÔ¶¨Î»×¢ÉäÍê³Éºó½«¶¯Îï·ÅÔÚ¼ÓÈȰå»òµÆ¹âÏÂÕÕÉä±£³ÖÌåΡ£´ý¶¯ÎïËÕÐѺó·Å»ØÁýÖС£Êõºó3ÌìÄÚÿÌ츹ǻעÉäÒ»´Î¿¹ÉúËØ¡£´óÔ¼90Ììºó¶¯Îï»áÖð½¥±íÏÖ³öÅÁ½ðÉ­±íÐÍ¡£

Copyright ? ÉϺ£AGÑÇÓ鼯ÍŹٷ½ÍøÕ¾ÉúÎï¼¼Êõ£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾    µØÖ·£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø¹ú¼ÊÒ½Ñ§Ô°Çø×ÏÆ¼Â·908Ū19ºÅÂ¥

AGÑÇÓ鼯ÍÅ¡¤(Öйú)¹Ù·½ÍøÕ¾

µã»÷ѯ¼Û

¡¾ÍøÕ¾µØÍ¼¡¿